The purpose of this legislation, known as the 340B PATIENTS Act of 2025, is to enhance access to discounted medications for healthcare providers serving low-income and vulnerable populations. It aims to clarify and strengthen the existing provisions of the 340B drug discount program, which allows certain healthcare entities to purchase outpatient drugs at reduced prices. The goal is to ensure that these entities can effectively use their savings to provide better care and services to their patients.